Nutrients · Nov 20, 2026

Renal Complement, Proteasome, and Inflammasome Alterations in Obesity-Associated NAFLD

By Sharma A, Hakkak R, Parajuli N

Background/Objectives: Obesity-associated nonalcoholic fatty liver disease (Ob-NAFLD) is associated with an increased risk of kidney injury; however, the cellular pathways contributing to renal damage remain incompletely understood. Our previous studies using the Zucker rat model demonstrated that Ob-NAFLD is associated with renal injury, inflammation, oxidative stress, apoptosis, and mitochondrial abnormalities, with only partial improvement following metformin treatment. These findings suggest that multiple interacting cellular stress pathways may contribute to the persistence of renal injury. Based on these findings, the present study examined complement-, proteasome-, and inflammasome-associated proteins as additional components of the renal pathology. Methods: Female lean and obese Zucker rats were maintained on an AIN-93G diet and assigned to four groups: Lean, Lean + metformin, Ob-NAFLD, and Ob-NAFLD + metformin. Metformin was incorporated into the diet at 1 g/kg for 10 weeks. Kidney tissues collected from these animals were analyzed via Western blotting for complement-associated proteins and fragments, constitutive and immunoproteasome components, and NLRP3 inflammasome-associated proteins. Results: Compared with lean controls, Ob-NAFLD kidneys showed significantly increased levels of the C3 processing fragments iC3b and iC3dg, C5α, and CD88/C5aR1, whereas C3α showed a nonsignificant increasing trend. Several constitutive proteasome subunits, including RPT6, PSMA4, and PSMB5, were elevated in Ob-NAFLD kidneys. Among the immunoproteasome subunits, PSMB8 was increased and PSMB10 showed a modest, nonsignificant increase, whereas PSMB9 was decreased. Levels of NLRP3, cleaved caspase-1, and pro-IL-1β were also increased in Ob-NAFLD kidneys. Metformin treatment was associated with a significant reduction in CD88/C5aR1 and cleaved caspase-1 levels in Ob-NAFLD kidneys, whereas C5α showed a nonsignificant downward trend. PSMB5 also showed a nominal reduction following metformin treatment, but this difference was not significant after adjustment for multiple comparisons. In contrast, iC3b, iC3dg, NLRP3, and pro-IL-1β levels remained elevated, while PSMB9 expression remained reduced following metformin treatment. Conclusions: Ob-NAFLD was associated with alterations in renal complement-associated proteins, selective proteasome remodeling, and increased expression of NLRP3 inflammasome-associated proteins. Although metformin modified selected protein levels, several Ob-NAFLD-associated abnormalities persisted despite treatment. These findings further define the molecular phenotype of Ob-NAFLD-associated renal injury and suggest persistent dysregulation of inflammatory and protein homeostasis pathways that warrant further investigation.

doi.org/10.3390/nu18223871Interventions

AgingResearch.News